Medical treatment that targets human proteins rather than ever-mutating viruses may one day help HIV-positive people whose bodies have built a resistance to ‘cocktails’ currently used to keep them healthy. Now researchers have pinpointed a protein variant that can be targeted to prevent the human immunodeficiency virus from harming HIV-positive individuals.